Spontaneous platelet aggregation in whole blood is increased in non-insulin-dependent diabetes mellitus and in female but not male patients with primary dyslipidemia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Atherosclerosis

• Publication date

  1995-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0021-9150(94)05417-HPMID 7772062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Formation of PGD(2) Contributes to the Anti-aggregatory Efficacy of ZD1542, a Thromboxane A(2) Synthase Inhibitor and TP Receptor Antagonist, in Human Whole Blood.

  1994cited by this paper
• The In Vitro Production of Thromboxane B2 by Platelets of Diabetic Patients Is Normal at Physiological Concentrations of lonized Calcium

  1993cited by this paper
• Platelet hyperaggregability across the coronary bed in response to rapid atrial pacing in patients with stable coronary artery disease.

  1992cited by this paper
• Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes.

  1992cited by this paper
• Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study.

  1992cited by this paper
• Big Platelets in Hyperlipidemic Patients

  1992cited by this paper
• Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.

  1992cited by this paper
• Effects of hypercholesterolemia on the nucleotide content in human blood cells

  1992cited by this paper
• Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitus.

  1991cited by this paper
• Shear-induced platelet aggregation.

  1990cited by this paper
• Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia.

  1990cited by this paper
• Platelet Aggregation in Whole Blood - Studies with a Platelet Counting Technique - Methodological Aspects and Some Applications

  1989cited by this paper
• Spontaneous Whole Blood Platelet Aggregation in Insulin-Dependent Diabetes Mellitus: An Evaluation in an Epidemiologic Study

  1989cited by this paper
• Comparison of two commercial nephelometric methods for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays.

  1989cited by this paper
• Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia

  1989cited by this paper
• The role of red blood cells in platelet aggregation in whole blood.

  1988cited by this paper
• Lipoproteins and the pathogenesis of atherosclerosis.

  1987cited by this paper
• Red blood cells mediate spontaneous aggregation of platelets in whole blood.

  1987cited by this paper
• Diabetes mellitus, vascular disease and thrombosis.

  1986cited by this paper
• Diabetes mellitus, vascular disease and thrombosis.

  1986cited by this paper
• Epidemiological characteristics of platelet aggregability.

  1985cited by this paper
• Inhibitors of "spontaneous" platelet aggregation in whole blood.

  1985cited by this paper
• A Comparison of Spontaneous Platelet Aggregation in Whole Blood with Platelet Rich Plasma: Additional Evidence for the Role of ADP

  1984cited by this paper
• Increased platelet sensitivity and thromboxane B2 formation in type‐II hyperlipoproteinaemic patients

  1984cited by this paper
• Characteristics of shear-induced aggregation in whole blood.

  1984cited by this paper
• Characteristics of shear-induced aggregation in whole blood.

  1984cited by this paper
• Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit.

  1984cited by this paper
• Effects of vascular trauma and transient myocardial ischaemia on coronary venous prostaglandin levels in the dog.

  1983cited by this paper
• Platelet Aggregation in Whole Blood Determined Using the Ultra-Flo 100 Platelet Counter

  1982cited by this paper
• Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro.

  1982cited by this paper
• Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.

  1982cited by this paper
• Lipids and thrombogenesis.

  1981cited by this paper
• Platelet function and platelet lipid composition in the dyslipoproteinemias.

  1980cited by this paper
• Sex-related differences in platelet aggregation: influence of the hematocrit.

  1980cited by this paper
• A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

  1978cited by this paper
• Sex and age differences in human platelet aggregation

  1975cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase

  2021influential citation
• THE EFFECT OF DIABETES ON CARDIOVASCULAR SYSTEM

  2017cites this paper
• State of the art in platelet function testing.

  2013cites this paper
• State of the Art in Platelet Function Testing

  2013cites this paper
• Platelet Activation, and Antiplatelet Targets and Agents

  2012cites this paper
• Risk Reduction in the Diabetic Patient

  2011cites this paper
• Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus.

  2009cites this paper
• Platelet activation, and antiplatelet targets and agents: current and novel strategies.

  2008cites this paper
• Platelet activation by collagen is increased in retinal vein occlusion

  2007cites this paper
• Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density Lipoprotein

  2006cites this paper
• Thyroid Disease: A Case-Based and Practical Guide for Primary Care

  2005cites this paper
• Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.

  2005cites this paper
• Diabetes Mellitus and Heart Disease

  2005cites this paper
• Diabetes and Thrombosis

  2005cites this paper
• Hydrogen peroxide formation in platelets of patients with non-insulin-dependent diabetes mellitus.

  1998cites this paper
• A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus.

  1998cites this paper
• Circulating platelet aggregates in glaucoma

  1998cites this paper
• Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes.

  1998cites this paper
• Insulin's Role as a Vascular Hormone in Health and Disease

  1998cites this paper
• Phosphorylation of Myosin Light Chain in Resting Platelets From NIDDM Patients Is Enhanced: Correlation With Spontaneous Aggregation

  1997cites this paper
• Diabetic human platelets release a substance that inhibits platelet-mediated vasodilation.

  1997cites this paper
• Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation.

  1996cites this paper